Skip to main content

Abstract

Acinetobacter baumannii is currently considered a major clinical pathogen accountable for causing several nosocomial infections and hospital outbreaks all over the globe. A. baumannii is accountable for causing bloodstream infections, pneumonia, meningitis, wound infection, urinary tract infection, endocarditis, peritonitis, and keratitis especially in individuals with low immunity. The pathogen has been reported to exhibit resistance against broad classes of antibiotics including carbapenems, aminoglycoside, quinolones, tetracyclines, cephalosporins, and polymyxin. Various virulence mechanisms have been identified and proposed for the resistance of A. baumannii towards the different class of antibiotics including inactivation or alteration of antimicrobials, alteration in membrane proteins, efflux pumps system, changes in the drug target, and biofilm formation. Furthermore, the ability to acquire and express exogenous antibiotic resistance genes is another contributing factor in imparting drug resistance to the pathogen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, Tsakris A (2014) Spread of carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect 86(4):260–266

    Article  CAS  PubMed  Google Scholar 

  • Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AM, El Kholy A (2014) Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis 22:49–54

    Article  CAS  PubMed  Google Scholar 

  • Almaghrabi MK, Joseph MRP, Assiry MM, Hamid ME (2018) Multidrug-resistant Acinetobacter baumannii: an emerging health threat in Aseer Region, Kingdom of Saudi Arabia. Can J Infect Dis Med Microbiol 2018:1

    Article  Google Scholar 

  • Almasaudi SB (2018) Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features. Saudi J Biol Sci 25(3):586–596

    Article  PubMed  Google Scholar 

  • Antunes LC, Visca P, Towner KJ (2014) Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 71(3):292–301

    Article  CAS  PubMed  Google Scholar 

  • Ardehali SH, Azimi T, Fallah F, Owrang M, Aghamohammadi N, Azimi L (2019) Role of efflux pumps in reduced susceptibility to tigecycline in Acinetobacter baumannii. New Microbes New Infect 30:100547

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Asif M, Alvi IA, Rehman SU (2018) Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist 11:1249–1260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Babapour E, Haddadi A, Mirnejad R, Angaji SA, Amirmozafari N (2016) Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance. Asian Pac J Trop Biomed 6(6):528–533

    Article  Google Scholar 

  • Badave GK, Kulkarni D (2015) Biofilm producing multidrug resistant Acinetobacter baumannii: an emerging challenge. J Clin Diagn Res 9(1):DC08–DC10

    PubMed  PubMed Central  Google Scholar 

  • Balkhy HH, El-Saed A, Maghraby R, Al-Dorzi HM, Khan R, Rishu AH, Arabi YM (2014) Drug-resistant ventilator associated pneumonia in a tertiary care hospital in Saudi Arabia. Ann Thorac Med 9(2):104–111

    Article  PubMed  PubMed Central  Google Scholar 

  • Cai Y, Chai D, Wang R, Liang B, Bai N (2012) Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 67(7):1607–1615

    Article  CAS  PubMed  Google Scholar 

  • Carvalho KR, Carvalho-Assef AP, Peirano G, Santos LC, Pereira MJ, Asensi MD (2009) Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents 34(1):25–28

    Article  CAS  PubMed  Google Scholar 

  • Chen KJ, Hou CH, Sun MH, Lai CC, Sun CC, Hsiao CH (2008) Endophthalmitis caused by Acinetobacter baumannii: report of two cases. J Clin Microbiol 46(3):1148–1150

    Article  PubMed  PubMed Central  Google Scholar 

  • Chopra T, Marchaim D, Awali RA, Krishna A, Johnson P, Tansek R, Kaye KS (2013) Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes. Antimicrob Agents Chemother 57(12):6270–6275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cisneros JM, Rodriguez-Bano J (2002) Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 8(11):687–693

    Article  CAS  PubMed  Google Scholar 

  • Coyne S, Courvalin P, Perichon B (2011) Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 55(3):947–953

    Article  CAS  PubMed  Google Scholar 

  • Doi Y, Murray GL, Peleg AY (2015) Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin Respir Crit Care Med 36(1):85–98

    Article  PubMed  PubMed Central  Google Scholar 

  • Gokmen TG, Akcimen B, Kayar B, Marzi M, Koksal F (2016) The outbreak of Acinetobacter baumannii producing OXA-23 and OXA-51 type carbapenemases in a state hospital. J Exp Clin Med 33(3):157–161

    Google Scholar 

  • Greene C, Vadlamudi G, Newton D, Foxman B, Xi C (2016) The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. Am J Infect Control 44(5):e65–e71

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harding CM, Hennon SW, Feldman MF (2018) Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol 16(2):91–102

    Article  CAS  PubMed  Google Scholar 

  • Hsu LY, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A, Tambyah PA (2017) Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia. Clin Microbiol Rev 30(1):1–22

    Article  PubMed  Google Scholar 

  • Inchai J, Pothirat C, Bumroongkit C, Limsukon A, Khositsakulchai W, Liwsrisakun C (2015) Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia. J Intensive Care 3:9

    Article  PubMed  PubMed Central  Google Scholar 

  • Jain M, Sharma A, Sen MK, Rani V, Gaind R, Suri JC (2019) Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Microb Pathog 128:75–81

    Article  CAS  PubMed  Google Scholar 

  • Khorsi K, Messai Y, Hamidi M, Ammari H, Bakour R (2015) High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes blaOXA-23-like, blaOXA-24-like and blaNDM-1 in Algiers hospitals. Asian Pac J Trop Med 8(6):438–446

    Article  CAS  PubMed  Google Scholar 

  • Kim BN, Peleg AY, Lodise TP, Lipman J, Li J, Nation R, Paterson DL (2009) Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 9(4):245–255

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lagana P, Melcarne L, Delia S (2015) Acinetobacter baumannii and endocarditis, rare complication but important clinical relevance. Int J Cardiol 187:678–679

    Article  CAS  PubMed  Google Scholar 

  • Lee K, Yong D, Jeong SH, Chong Y (2011) Multidrug-resistant Acinetobacter spp: increasingly problematic nosocomial pathogens. Yonsei Med J 52(6):879–891

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Lee SH (2017) Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol 7:55

    PubMed  PubMed Central  Google Scholar 

  • Lolans K, Rice TW, Munoz-Price LS, Quinn JP (2006) Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 50(9):2941–2945

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Manchanda V, Sanchaita S, Singh N (2010) Multidrug resistant acinetobacter. J Global Infect Dis 2(3):291–304

    Article  Google Scholar 

  • Maragakis LL, Perl TM (2008) Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46(8):1254–1263

    Article  CAS  PubMed  Google Scholar 

  • Mesli E, Berrazeg M, Drissi M, Bekkhoucha SN, Rolain JM (2013) Prevalence of carbapenemase-encoding genes including New Delhi metallo-beta-lactamase in Acinetobacter species Algeria. Int J Infect Dis 17(9):e739–e743

    Article  CAS  PubMed  Google Scholar 

  • Necati Hakyemez I, Kucukbayrak A, Tas T, Burcu Yikilgan A, Akkaya A, Yasayacak A, Akdeniz H (2013) Nosocomial Acinetobacter baumannii infections and changing antibiotic resistance. Pak J Med Sci 29(5):1245–1248

    PubMed  PubMed Central  Google Scholar 

  • Oh YJ, Song SH, Baik SH, Lee HH, Han IM, Oh DH (2013) A case of fulminant community-acquired Acinetobacter baumannii pneumonia in Korea. Korean J Intern Med 28(4):486–490

    Article  PubMed  PubMed Central  Google Scholar 

  • Pagano M, Martins AF, Barth AL (2016) Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii. Braz J Microbiol 47(4):785–792

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rezaee MA, Pajand O, Nahaei MR, Mahdian R, Aghazadeh M, Ghojazadeh M, Hojabri Z (2013) Prevalence of Ambler class A beta-lactamases and ampC expression in cephalosporin-resistant isolates of Acinetobacter baumannii. Diagn Microbiol Infect Dis 76(3):330–334

    Article  CAS  PubMed  Google Scholar 

  • Rogers AD, Deal C, Argent AC, Hudson DA, Rode H (2014) Ventilator associated pneumonia in major paediatric burns. Burns 40(6):1141–1148

    Article  PubMed  Google Scholar 

  • Santajit S, Indrawattana N (2016) Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int 2016:2475067

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Senkyrikova M, Husickova V, Chroma M, Sauer P, Bardon J, Kolar M (2013) Acinetobacter baumannii producing OXA-23 detected in the Czech Republic. SpringerPlus 2(1):296

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sharma A, Sharma R, Bhattacharyya T, Bhando T, Pathania R (2017) Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter-AbaF. J Antimicrob Chemother 72(1):68–74

    Article  CAS  PubMed  Google Scholar 

  • Shoja S, Moosavian M, Rostami S, Farahani A, Peymani A, Ahmadi K, Ebrahimifard N (2017) Dissemination of carbapenem-resistant Acinetobacter baumannii in patients with burn injuries. J Chin Med Assoc 80(4):245–252

    Article  PubMed  Google Scholar 

  • Singh H, Thangaraj P, Chakrabarti A (2013) Acinetobacter baumannii: a brief account of mechanisms of multidrug resistance and current and future therapeutic management. J Clin Diagn Res 7(11):2602–2605

    PubMed  PubMed Central  Google Scholar 

  • Subashchandrabose S, Smith S, DeOrnellas V, Crepin S, Kole M, Zahdeh C, Mobley HL (2016) Acinetobacter baumannii genes required for bacterial survival during bloodstream infection. mSphere 1(1):e00013

    Article  PubMed  Google Scholar 

  • Vila J, Marti S, Sanchez-Cespedes J (2007) Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 59(6):1210–1215

    Article  CAS  PubMed  Google Scholar 

  • Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A, Millar M (2008) Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis 27(7):607–612

    Article  CAS  PubMed  Google Scholar 

  • Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B (2017) Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev 30(1):409–447

    CAS  PubMed  Google Scholar 

  • Xu C, Bilya SR, Xu W (2019) adeABC efflux gene in Acinetobacter baumannii. New Microbes New Infect 30:100549

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang W, Wu YG, Qi XM, Dai H, Lu W, Zhao M (2014) Peritoneal dialysis-related peritonitis with Acinetobacter baumannii: a review of seven cases. Perit Dial Int 34(3):317–321

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rajkumari, J., Siddhardha, B. (2020). Acinetobacter baumannii: Infections and Drug Resistance. In: Siddhardha, B., Dyavaiah, M., Syed, A. (eds) Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery. Springer, Singapore. https://doi.org/10.1007/978-981-15-1695-5_14

Download citation

Publish with us

Policies and ethics